Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aldose reductase inhibitor, fidarestat regulates mitochondrial biogenesis via Nrf2/HO-1/AMPK pathway in colon cancer cells
Kirtikar Shukla, Himangshu Sonowal, Ashish Saxena, et al.
Cancer Letters (2017) Vol. 411, pp. 57-63
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Regulation of Mitochondrial Biogenesis as a Way for Active Longevity: Interaction Between the Nrf2 and PGC-1α Signaling Pathways
Artem P. Gureev, Ekaterina A. Shaforostova, В. Н. Попов
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 501
The Role of Nrf2 Activity in Cancer Development and Progression
Alina‐Andreea Zimța, Diana Cenariu, Alexandru Irimie, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1755-1755
Open Access | Times Cited: 228
Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2/Nrf2 and mitochondria
In-geun Ryoo, Mi‐Kyoung Kwak
Toxicology and Applied Pharmacology (2018) Vol. 359, pp. 24-33
Closed Access | Times Cited: 201
Celastrol induces ROS-mediated apoptosis via directly targeting peroxiredoxin-2 in gastric cancer cells
Xi Chen, Ying Zhao, Wu Luo, et al.
Theranostics (2020) Vol. 10, Iss. 22, pp. 10290-10308
Open Access | Times Cited: 198
Potential Applications of NRF2 Inhibitors in Cancer Therapy
Emiliano Panieri, Luciano Saso
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-34
Open Access | Times Cited: 161
The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway
Qiongyuan Hu, Jianan Ren, Guanwei Li, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 142
Role of aldo‐keto reductase family 1 member B1 (AKR1B1) in the cancer process and its therapeutic potential
Reza Khayami, Seyyed Reza Hashemi, Mohammad Amin Kerachian
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 16, pp. 8890-8902
Open Access | Times Cited: 79
The role of mitochondrial biogenesis, mitochondrial dynamics and mitophagy in gastrointestinal tumors
Yi‐Hong Liu, Hao Wang, Shen Zhang, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
Emiliano Panieri, Pelin Telkoparan‐Akillilar, Síbel Süzen, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 791-791
Open Access | Times Cited: 69
Isolation of strawberry anthocyanin-rich fractions and their mechanisms of action against murine breast cancer cell lines
Luca Mazzoni, Francesca Giampieri, José M. Álvarez‐Suarez, et al.
Food & Function (2019) Vol. 10, Iss. 11, pp. 7103-7120
Closed Access | Times Cited: 60
Mechanistic insights into AMPK-SIRT3 positive feedback loop-mediated chondrocyte mitochondrial quality control in osteoarthritis pathogenesis
Yang Chen, Yongyao Wu, Haibo Si, et al.
Pharmacological Research (2021) Vol. 166, pp. 105497-105497
Closed Access | Times Cited: 50
PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells
Chen Liang, Si Shi, Mingyang Liu, et al.
Cancer Research (2018) Vol. 79, Iss. 1, pp. 133-145
Open Access | Times Cited: 58
Moving toward a new horizon for the aldose reductase inhibitor epalrestat to treat drug-resistant cancer
Christian Bailly
European Journal of Pharmacology (2022) Vol. 931, pp. 175191-175191
Closed Access | Times Cited: 23
Cognitive protection of sinomenine in type 2 diabetes mellitus through regulating the EGF/Nrf2/HO‐1 signaling, the microbiota‐gut‐brain axis, and hippocampal neuron ferroptosis
Ji Chen, Peng Guo, Mingming Han, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 8, pp. 3323-3341
Closed Access | Times Cited: 16
Phelligridimer A enhances the expression of mitofusin 2 and protects against cerebral ischemia/reperfusion injury
Xing Li, Bingtian Xu, Lu Long, et al.
Chemico-Biological Interactions (2024) Vol. 398, pp. 111090-111090
Closed Access | Times Cited: 5
Targeted co-delivery of the aldose reductase inhibitor epalrestat and chemotherapeutic doxorubicin via a redox-sensitive prodrug approach promotes synergistic tumor suppression
Venkatesh Teja Banala, Sandeep Urandur, Shweta Sharma, et al.
Biomaterials Science (2019) Vol. 7, Iss. 7, pp. 2889-2906
Closed Access | Times Cited: 40
Anti-inflammatory effects of higenamine (Hig) on LPS-activated mouse microglia (BV2) through NF-κB and Nrf2/HO-1 signaling pathways
Songwei Yang, Shifeng Chu, Qidi Ai, et al.
International Immunopharmacology (2020) Vol. 85, pp. 106629-106629
Closed Access | Times Cited: 34
Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri, Luciano Saso
Antioxidants and Redox Signaling (2021) Vol. 34, Iss. 18, pp. 1428-1483
Closed Access | Times Cited: 30
Silibinin protects against sepsis and septic myocardial injury in an NR1H3-dependent pathway
Meng Sun, Huadong Zhao, Zhenxiao Jin, et al.
Free Radical Biology and Medicine (2022) Vol. 187, pp. 141-157
Closed Access | Times Cited: 19
Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis
Syamprasad NP, Bishal Rajdev, Siddhi Jain, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110145-110145
Closed Access | Times Cited: 12
Proteomics-based screening of AKR1B1 as a therapeutic target and validation study for sepsis-associated acute kidney injury
Lei Li, Zaiqin Ling, Xinsheng Wang, et al.
PeerJ (2024) Vol. 12, pp. e16709-e16709
Open Access | Times Cited: 4
The Dual Role of NRF2 in Colorectal Cancer: Targeting NRF2 as a Potential Therapeutic Approach
Mengyun Hu, Lingling Yuan, Jie Zhu
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5985-6004
Open Access | Times Cited: 4
AKR1B1 Inhibits Ferroptosis and Promotes Gastric Cancer Progression via Interacting With STAT3 to Activate SLC7A11
Kaiyan Yang, Xin Zhang, Fei Long, et al.
Cell Biology International (2025)
Closed Access
Potential protective role of Lycium ruthenicum Murray polysaccharides against lipopolysaccharide-induced liver injury via mitochondrial biogenesis
Wenjia Wang, Desheng Wu, Jiaguo Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 141365-141365
Closed Access
Antioxidant and Anti-Inflammatory Defenses in Huntington’s Disease: Roles of NRF2 and PGC-1α, and Therapeutic Strategies
Francesco D’Egidio, Elvira Qosja, Fabrizio Ammannito, et al.
Life (2025) Vol. 15, Iss. 4, pp. 577-577
Open Access
Page 1 - Next Page

Scroll to top